KRAS Mutation-Related Tumors
14 clinical trials · Condition
◉ Watch KRAS Mutation-Related Tumors
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Response to Tyrosine Kinase Inhibitors in Localized Non-small Cell Lung Cancer (NSCLC) Patients With EGFR Mutation in a Patient-derived Organoid Model (NCT05136014) | Central Hospital, Nancy, France | 2021-11-01 |
| A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors (NCT05071183) | Turning Point Therapeutics, Inc. | 2021-09-23 |
| Patogenic Mutation in 5 Genes (NCT04976439) | Dr Cipto Mangunkusumo General Hospital | 2021-05-01 |
| Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer (NCT04735068) | Abramson Cancer Center at Penn Medicine | 2021-04-09 |
| A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer (NCT03597581) | Inspirna, Inc. | 2018-06-05 |
| CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer (NCT04560270) | Poitiers University Hospital | 2016-04-25 |
Track KRAS Mutation-Related Tumors automatically
Every clearance here is in the API, with alerts when new ones post.